Experimental Chemotherapy against Canine Mammary Cancer Xenograft in SCID Mice and Its Prediction of Clinical Effect

Journal of Veterinary Medical Science

Volumn 63, Issue 8, 2001, Pages 831-836

  Yamashita, Atsuko ^a   Maruo, Kohji ^a   Suzuki, Kaoru ^a   Shirota, Kinji ^b   Kobayashi, Kimio ^c   Hioki, Kyoji ^c  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b AZABU UNIVERSITY   (Japan)

^c Ctrl Inst of Experimental Animals   (Japan)

Author keywords

Canine; Chemotherapy; Mammary cancer; SCID mouse; Xenograft

Indexed keywords

CANIS FAMILIARIS;

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; VINBLASTINE; VINCRISTINE;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; CYTOCHEMISTRY; DOG; DOG DISEASE; DRUG SCREENING; EXPERIMENTAL NEOPLASM; FEMALE; MOUSE; MOUSE MUTANT; NONPARAMETRIC TEST; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DOG DISEASES; DOGS; DOXORUBICIN; FEMALE; FLUOROURACIL; HISTOCYTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, SCID; STATISTICS, NONPARAMETRIC; VINBLASTINE; VINCRISTINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035432145     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.63.831     Document Type: Article

References (39)

1. Bosma, G. C., Custer, R. P. and Bosma, M. J. 1983. A severe combined immunodeficiency mutation in the mouse. Nature (Lond.) 301: 527-530.
2. Brodey, R. S., Goldschmidt, M. H. and Roszel, J. R. 1983. Canine mammay, gland neoplasms. J. Am. Anim. Hosp. Assoc. 19: 61-90.
3. Buzdar, A. U., McNeese, M. D., Hortobagyi, G. N., Smith, T. L., Kau, S., Fraschini, G., Hug, V., Ellerbroek, N., Holmes, F. A. and Ames, F., et al. 1990. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer 65: 394-399.
4. Carter, S.K. and Livingston, R.B. 1981. Principles of cancer chemotherapy. pp.95-110. In: Principles of Cancer Treatment (Carter, S.K., Glatstein, E. and Livingston, R.B. eds), McGraw-Hill, New York.
5. Chabner, B.A. 1982. The role of drugs in cancer treatment. pp. 3-14. In: Pharmacologic Principles of Cancer Treatment (Chabner, B.A. ed.), W.B. Saunders, Philadelphia.
6. Creasey, W.A., Scott, A.I., Wei, C.C., Kutcher, J., Schwartz, A. and Marsh, J.C. 1975. Pharmacological studies with vinblastine in the dog. Cancer Res. 35: 1116-1120.
7. Damon, L. E. and Cadman, E. C. 1986. Advances in rational combination chemotherapy. Cancer Invest. 4: 421-144.
8. Didolkar, M. S., Covell, D. G., Jackson, A. J., Walker, A. P. and Kalidindi, S. R. 1984. Pharmacokinetics of 5-fluorouracil following different routes of intrahepatic administration in the canine model. Cancer Res. 44: 5105-5109.
9. El Dareer, S. M., White, V. M., Chen, F. P., Mellet, L. B. and Hill, D. L. 1977. Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys. Cancer Treat. Rep. 61: 1269-1277.
10. Fidler, I. J. and Brodey, R. S. 1967. The biological behavior of canine mammary neoplasms. J. Am. Vet. Med. Assoc. 151: 1311-1318.
11. Harvey, H. J. and Gilbertson, S. R. 1977. Canine mammary gland tumors. Vet. Clin. North. Am. 7: 213-219.
12. Hill, D. L. 1975. Pharmacology. pp. 60-85. In: A Review of Cyclophosphamide. Charles C Thomas Publisher, Illinois.
13. Hill, L. L., Korngold, R., Jaworsky, C., Murphy, G., McCue, P. and Berd, D. 1991. Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency. Cancer Res. 51: 4931-4941.
14. Iguchi, H., Tone, H., Ishikura, T., Takeuchi, T. and Umezawa, H. 1985. Pharmacokinetics and disposition of 4′-O-tetrahydropyranyladriamycin in mice by HPLC analysis. Cancer Chemother. Pharmacol. 15: 132-140.
15. Iguchi, H., Tone, H., Kiyosaki, T., Ishikura, T., Takeuchi, T. and Umezawa, H. 1986. Pharmacokinetics and disposition of (2″R)-4′-O-tetrahydropyranyladriamycin in dogs. Jpn. J. Antibiot. 39: 638-652.
16. Inaba, M., Kobayashi, T., Tashiro, T. and Sakurai, Y. 1988. Pharmacokinetic approach to rational therapeutic doses for human tumor- bearing nude mice. Jpn. J. Cancer Res. 79: 509-516.
17. Inaba, M., Tashiro, T., Kobayashi, T., Sakurai, Y., Maruo, K., Ohnishi, Y., Ueyama, Y. and Nomura, T. 1988. Responsiveness of human gastric tumors implanted in nude mice to clinically equivalent doses of various antitumor agents. Jpn. J. Cancer Res. 79: 517-522.
18. Kim, D. K., Kim, H. T., Tai, J. H., Cho, Y. B., Kim, T. S., Kim, K. H., Park, J.G. and Hong, W. S. 1995. Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato [(4R, 5R)- 4,5-bis (aminomethyl) - 2-isopropyl-1,3- dioxolane] platinum(II), as determined by ex vivo pharmacodynamics. Cancer Chemother. Pharmacol. 37: 1-6.
19. MacEwen, E. G. and Withrow, J. S. 1996. Tumors of the mammary gland. pp. 356-372. In: Small Animal Clinical Oncology, 2nd ed. (Withrow, J. S. and MacEwen, E.G. eds.), W. B. Saunders Company, Philadelphia.
20. Maruo, K., Ueyama, Y., Inaba, M., Emura, R., Ohnishi, Y., Nakamura, O., Sato, O. and Nomura, T. 1990. Responsiveness of subcutaneous human glioma xenografts to various antitumor agents. Anticancer Res. 10: 209-212.
21. Moore, A. S. and Frimberger, A. E. 2000. Principles of chemotherapy. pp. 484-489. In: Textbook of Veterinary Internal Medicine, 5th ed. (Ettinger, S. J. and Feldman, E. C. eds.), W. B. Saunders Company, Philadelphia.
22. Moulton, J. E. 1990. Tumors of the mammary gland. pp. 518-552. In: Tumors in Domestic Animals, 3rd ed.(Moulton, J.E. ed), University of California Press, California.
23. Nomura, T., Takahama, Y., Hongyo, T., Takatera, H., Inohara, H., Fukushima, H., Ono, S. and Hamaoka, T. 1991. Rapid growth and spontaneous metastasis of human germinal tumors ectopically transplanted into seid (severe combined immunodeficiency) and Scid-nude streaker mice. Jpn. J. Cancer Res. 82: 701-709.
24. Ogilvie, G. K. 1996. Chemotherapy. pp. 70-86. In: Small Animal Clinical Oncology. 2nd ed. (Withrow, J. S. and MacEwen, E. G. eds.), W. B. Saunders Company, Philadelphia.
25. Okamoto, Y., Takao, A. and Fujita, H. 1990. Pharmacokinetics of cisplatin and new cisplatin analogues in experimental animals. Chemotherapy 38: 639-645 (in Japanese).
26. Ozawa, S., Sugiyama, Y., Mitsuhashi, J. and Inaba, M. 1989. Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells. Cancer Res. 49: 3823-3828.
27. Ozawa, S., Sugiyama, Y., Mitsuhashi, Y., Kobayashi, T. and Inaba, M. 1988. Cell killing action of cell cycle phase - non-specific antitumor agents is dependent on concentration-time product. Cancer Chemother. Pharmacol. 21: 185-190.
28. Pantelouris, E. M. 1968. Absence of thymus in a mouse mutant. Nature (Lond.) 217: 370-371.
29. Povlsen, C. O. and Jacobsen, G. K. 1975. Chemotherapy of a human malignant melanoma transplanted in the nude mouse. Cancer Res. 35: 2790-2796.
30. Povlsen, C. O. and Rygaard, J. 1974. Effects of cyclophosphamide (endoxan) on a Burkitt's lymphoma serially grown in nude mice. pp. 285-292. In: Proceedings of the First International Workshop on Nude Mice (Rygaard, J. and Povlsen, C.O., eds.), Stuttgart, Verlag.
31. Rosenthal, R. C. 1988. The impact of pharmacokinetics on cancer chemotherapy. Vet. Clin. North Am. Small Anim. Pract. 18: 1133-1139.
32. Rupniak, H. T., Whelan, R. D. and Hill, B. T. 1983. Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro. Int. J. Cancer 32: 7-12.
33. Shimoyama, M. 1976. Implication of cell-kill-kinetics of anticancer agents in the design of optional therapeutic schedules. Gan To Kagaku Ryoho 3: 1103-1110 (in Japanese).
34. Sugiyama, Y. 1985. Physiological pharmacokinetics: basic theory. pp. 385-430. In: Applied Pharmacokinetics - Theory and Experiments - (Hanano, K. and Iga, T. eds.), Soft Science Inc., Tokyo (in Japanese).
35. Tormey, D.C., Gray, R., Gilchrist, K., Grage, T., Carbone, P.P., Wolter, J.E. and Cummings, F.J. 1990. Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial. Cancer 65: 200-206.
36. Uchida, N., Takeda, Y., Kasai, H., Hojo, K., Wada, T., Nishida, K., Maekawa, R., Sugita, K. and Yoshioka, T. 1998. Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model. Gan To Kagaku Ryoho 25: 2267-2274 (in Japanese).
37. van Tellingen, O., Beijnen, J. H., Nooijen, W. J. and Bult, A. 1993. Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography. Cancer Res. 53: 2061-2065.
38. Xie, X., Brunner, N., Jensen, G., Albrectsen, J., Gotthardsen, B. and Rygaard, J. 1992. Comparative studies between nude and seid mice on the growth and metastatic behavior of xenografted human tumors. Clin. Exp. Metastasis 10: 201-210.
39. Yoshimura, M., Endo, S., Hioki, K., Ueyama, Y. and Ohnishi, Y. 1997. Chemotherapeutic profiles of human tumors implanted in SCID mice showing appreciable inconsistencies with those in nude mice. Exp. Anim. (Tokyo) 46: 153-156.